Voyager Reports Second Quarter 2026 Financial and Operating Results
Globe Newswire•06/08/2026•16:01 ET
0
Whiz Insights
- VY7523 clinical data and VY1706 clinical entry, both in Alzheimer’s, expected Q4 2026 -
Ended Q2 2026 with cash position of $149 million, runway into 2028 -
Get started
Create a free account to read the full story.